Population
354 patients from Germany hospitalized between 2000 and 2008 at temporary high risk of sudden arrhythmic death
Design
Review
Follow-up
mean 3 months
Authors
Loading...
May support bridging use in select high-risk patients; leaves open need for randomized trials to confirm benefit.
The wearable cardioverter defibrillator provides a temporary safeguard against sudden arrhythmic death for patients awaiting ICD implantation or recovery of ventricular function.
Klein et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: